Last quarter (Q ), Sorrento Therapeutics's total revenue was $10.60M, a decrease of -42.36% from the same quarter last year. In Q, Sorrento Therapeutics's net income was $-139.62M. See Sorrento Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 55.05M	$ 62.84M	$ 52.90M	$ 39.99M	$ 31.43M	$ 21.19M
Cost of Revenue	$ 26.87M	$ -4.54M	$ 13.03M	$ 9.94M	$ 12.24M	$ 7.06M
Gross Profit	$ 481.00K	$ 29.68M	$ 39.87M	$ 30.05M	$ 19.20M	$ 14.13M
Operating Expense	$ 418.69M	$ 407.89M	$ 407.92M	$ 231.57M	$ 214.38M	$ 143.61M
Operating Income	$ -418.21M	$ -378.21M	$ -368.05M	$ -201.53M	$ -195.18M	$ -129.48M
Net Non Operating Interest Income Expense	$ -3.76M	$ -8.57M	$ -10.22M	$ -20.16M	$ -35.05M	$ -56.71M
Other Income Expense	$ -20.20M	$ 128.63M	$ -84.26M	$ -88.90M	$ -129.35M	$ -27.59M
Pretax Income	$ -665.59M	$ -561.75M	$ -462.53M	$ -310.58M	$ -359.58M	$ -213.78M
Tax Provision	$ 7.59M	$ -2.42M	$ -33.52M	$ -2.01M	$ -473.00K	$ -6.27M
Earnings From Equity Interest Net Of Tax	$ -18.66M	$ -18.43M	$ -126.00K	$ -5.84M	$ -3.91M	$ -5.02M
Net Income Common Stockholders	$ -671.64M	$ -572.84M	$ -428.32M	$ -298.46M	$ -292.07M	$ -203.54M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 445.56M	$ 403.35M	$ 420.95M	$ 241.51M	$ 226.61M	$ 150.67M
Net Income From Continuing And Discontinued Operation	$ -686.65M	$ -572.84M	$ -428.32M	$ -298.46M	$ -292.07M	$ -203.54M
Normalized Income	$ -202.21M	-	$ -376.02M	$ -211.51M	$ -163.09M	$ -176.90M
Interest Expense	$ 3.11M	-	$ 10.22M	$ 20.16M	$ 36.14M	$ 57.63M
EBIT	$ -661.83M	$ -553.17M	$ -452.30M	$ -290.42M	$ -323.44M	$ -156.15M
EBITDA	$ -632.75M	$ -548.85M	$ -439.84M	$ -279.42M	$ -312.45M	$ -146.66M

Currency in USD

Sorrento Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing